Alan R. Yuen

1.9k total citations
22 papers, 1.5k citations indexed

About

Alan R. Yuen is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan R. Yuen has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan R. Yuen's work include Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Alan R. Yuen is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Alan R. Yuen collaborates with scholars based in United States and Canada. Alan R. Yuen's co-authors include Sandra J. Horning, Jerry Halpern, Yafei Hou, Edgar G. Engleman, Claudia Benike, George A. Fisher, Lawrence Fong, Mark M. Davis, Alberto Rivas and Saul A. Rosenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Alan R. Yuen

21 papers receiving 1.5k citations

Peers

Countries citing papers authored by Alan R. Yuen

Since Specialization

Citations

This map shows the geographic impact of Alan R. Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R. Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R. Yuen more than expected).

Fields of papers citing papers by Alan R. Yuen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan R. Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R. Yuen. The network helps show where Alan R. Yuen may publish in the future.

Co-authorship network of co-authors of Alan R. Yuen

This figure shows the co-authorship network connecting the top 25 collaborators of Alan R. Yuen. A scholar is included among the top collaborators of Alan R. Yuen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan R. Yuen. Alan R. Yuen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience 2013 ·Blood ·Daryl Tan, Sandra J. Horning, Richard T. Hoppe, Ronald Levy, Saul A. Rosenberg, Bronislava M. Sigal, Roger A. Warnke, Yasodha Natkunam, Summer S. Han, Alan R. Yuen, Sylvia K. Plevritis, Ranjana H. Advani	180
2	Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003. 2007 ·Blood ·Daryl Tan, Saul A. Rosenberg, Ronald Levy, Philip W. Lavori, Robert Tibshirani, Richard T. Hoppe, Roger A. Warnke, Ranjana H. Advani, Yasodha Natkunam, Alan R. Yuen, Sandra J. Horning	11
3	Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma 2004 ·Clinical Cancer Research ·William Larry Gluck, Deborah Hurst, Alan R. Yuen, Alexandra M. Levine, Mark A. Dayton, Jon P. Gockerman, Jennifer B. Lucas, Kimberly Denis-Mize, Barbara Tong, (unknown), A. DiFrancesco, (unknown), Susan E. Wilson, (unknown)	127
4	Distribution of monoclonal antiferritin antibody in Kaposi's sarcoma, Hodgkin's disease, and hepatocellular carcinoma 2003 ·Human Pathology ·Alan R. Yuen, Julian P. T. Higgins, Robin J. Baker, Onsi W. Kamel, Roger A. Warnke, Susan J. Knox	1
5	Clinical Outcomes Associated with very Late Relapses in Diffuse Large Cell Lymphoma 2002 ·Leukemia & lymphoma ·Andrew H. Ko, Alan R. Yuen	7
6	Spontaneously Relapsing Clonal, Mucosal Cytotoxic T-Cell Lymphoproliferative Disorder 2000 ·The American Journal of Surgical Pathology ·Erik A. Ranheim, Carol D. Jones, James L. Zehnder, Roger A. Warnke, Alan R. Yuen	34
7	Similar outcome of elderly patients in Intergroup Trial 0096 2000 ·Cancer ·Alan R. Yuen, Guangyong Zou, Andrew T. Turrisi, William T. Sause, Ritsuko Komaki, Henry Wagner, Seena C. Aisner, Robert B. Livingston, Ronald H. Blum, (unknown)	94
8	Similar outcome of elderly patients in Intergroup Trial 0096 2000 ·Cancer ·Alan R. Yuen, Guangyong Zou, Andrew T. Turrisi, William T. Sause, Ritsuko Komaki, Henry Wagner, Seena C. Aisner, Robert B. Livingston, Ronald H. Blum, David H. Johnson	29
9	Clinical studies of antisense therapy in cancer 2000 ·Frontiers in bioscience ·Alan R. Yuen	9
10	Progress in the non-Hodgkin's lymphomas 1999 ·Annals of Oncology ·Alan R. Yuen	4
11	<title>Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer</title> 1998 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Markus F. Renschler, Alan R. Yuen, Timothy J. Panella, (unknown), (unknown), Laura J. Esserman, Masoud Panjehpour, (unknown), Victor H. Fingar, Elizabeth Lowe, J Engel, Bert L. Lum, Kathryn W. Woodburn, Wai‐Fung Cheong, Richard Miller	22
12	Recent advances in the treatment of Hodgkinʼs disease 1997 ·Current Opinion in Hematology ·Alan R. Yuen, (unknown)	2
13	Recent advances in Hodgkinʼs disease 1996 ·Current Opinion in Hematology ·Alan R. Yuen, Sandra J. Horning	3
14	Hodgkin's disease: management of first relapse. 1996 ·PubMed ·Alan R. Yuen, Sandra J. Horning	34
15	Long-term survival after histologic transformation of low-grade follicular lymphoma. 1995 ·Journal of Clinical Oncology ·Alan R. Yuen, Onsi W. Kamel, Jerry Halpern, Sandra J. Horning	127
16	Recent advances in Hodgkinʼs disease 1995 ·Current Opinion in Hematology ·Alan R. Yuen, Sandra J. Horning	0
17	Multidrug resistance in lymphomas. 1994 ·Journal of Clinical Oncology ·Alan R. Yuen, Branimir I. Šikić	98
18	Impact of omeprazole on the plasma clearance of methotrexate 1993 ·Cancer Chemotherapy and Pharmacology ·Tony Reid, Alan R. Yuen, (unknown), Robert W. Carlson	45
19	A quantitative Golgi study in the occipital cortex of the pyramidal dendritic topology of old adult rats from social or isolated environments 1982 ·Brain Research ·James R. Connor, (unknown), (unknown), Alan R. Yuen, Marian C. Diamond	26
20	Dendritic length in aged rats' occipital cortex: An environmentally induced response 1981 ·Experimental Neurology ·James R. Connor, (unknown), Alan R. Yuen, Marian C. Diamond	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact